Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study

Aims: To assess real-world effectiveness and safety of intravenous (IV) HX575, a biosimilar epoetin-α, in hemodialysis (HD) patients. Materials and methods: This prospective, observational, pharmacoepidemiological study of adult HD patients treated with IV HX575 for renal anemia for up to 24 months...

Descripción completa

Detalles Bibliográficos
Autores principales: London, Gérard, Mann, Johannes, Goldsmith, David, Combe, Christian, Dellanna, Frank , Zaoui, Philippe, Hoebel, Nadja, Krendyukov, Andriy, MacDonald, Karen, Abraham, Ivo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735817/
https://www.ncbi.nlm.nih.gov/pubmed/29168688
http://dx.doi.org/10.5414/CN109245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735817/
https://www.ncbi.nlm.nih.gov/pubmed/29168688
http://dx.doi.org/10.5414/CN109245

Ejemplares similares